U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117981) titled 'Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment.' on July 29.
Brief Summary: Describe the progression of inflammatory orbitopathy and the biological progression of patients receiving second-line treatment (immunosuppressants, radiotherapy, or biotherapy).
Study Start Date: Nov. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Basedow Disease
Recruitment Status: RECRUITING
Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Published by HT Digital Content Services with permission from Health Daily Digest....